Black Health
CNS stimulant (Schedule II) ADHD Narcolepsy

Amphetamine/Dextroamphetamine (Adderall, Adderall XR, Mydayis) and Black patients

Brand names: Adderall, Adderall XR, Mydayis

Last reviewed: Sources checked:

What Amphetamine/Dextroamphetamine does

Adderall is a mixed-amphetamine-salts stimulant used for ADHD and narcolepsy. It increases dopamine and norepinephrine signaling in the brain, improving focus and attention. It is a Schedule II controlled substance with meaningful abuse potential.

What the evidence says for Black patients

ADHD diagnosis and treatment are significantly race-biased in the US:

  • Diagnostic gap. Black children with ADHD are 30–50 percent less likely to be diagnosed than white children with similar symptoms, according to multiple analyses of CDC and school-health data (Morgan et al., Pediatrics 2013;132:85–93, PMID 23796743). Under-diagnosis compounds across adolescence into adulthood.
  • Treatment gap. Among diagnosed Black children, stimulant prescription rates are lower than among white children. Reasons include parental stigma, access to specialty care, and clinician hesitation.
  • Criminalization risk. Black adults carrying Schedule II prescriptions face disproportionate scrutiny at traffic stops and in hospitals. Having a current, labeled prescription (not a pill bottle with loose pills) and knowing the specific protections in one's state is practical advice.
  • 2022–2024 Adderall shortage. National manufacturing issues and DEA quota caps caused widespread shortages. Black patients with fewer backup pharmacies, less flexibility to travel, and less-connected prescribers face disproportionate interruptions.
  • Cardiovascular risk. Stimulants modestly raise heart rate and blood pressure. For Black adults with baseline hypertension, BP and HR should be checked before and during treatment.

Common alternatives

Methylphenidate (Ritalin, Concerta, Focalin) — different stimulant class, sometimes better tolerated. Atomoxetine (Strattera) — non-stimulant, lower abuse potential but slower onset. Guanfacine, clonidine extended-release — non-stimulant alternatives, especially in children with tics or sleep issues.

Side effects

  • Decreased appetite, weight loss
  • Insomnia
  • Elevated BP, heart rate
  • Anxiety, jitteriness
  • Abuse potential, dependency
  • Psychosis (rare, with very high doses or susceptible patients)
  • Sudden cardiac events (rare; black-box warning in structural heart disease)

Factors that affect adherence

Schedule II drugs require a new paper or electronic prescription every 30 days. Refills are not permitted, and early refills are flagged. Plan ahead. Keep the original bottle with prescription label.

Questions to ask your doctor

Bring this list to your next appointment.

  • If I or my child's ADHD symptoms seem under-recognized, how do we formalize the diagnosis?
  • What's my BP/HR baseline, and how will we monitor?
  • If there's a shortage, what's our backup — a different stimulant, or a non-stimulant option?
  • Do I need a cardiology evaluation before starting?

References

  1. Morgan PL, Staff J, Hillemeier MM, et al. Racial and ethnic disparities in ADHD diagnosis from kindergarten to eighth grade. Pediatrics. 2013;132:85–93. PMID 23796743.
  2. Coker TR, Elliott MN, Toomey SL, et al. Racial and ethnic disparities in ADHD diagnosis and treatment. Pediatrics. 2016;138:e20160407.
  3. Cortese S, Adamo N, Del Giovane C, et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2018;5:727–738.
  4. U.S. Food and Drug Administration. Adderall XR (mixed salts of amphetamine) label. https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021303s026lbl.pdf

Medical disclaimer

This page is patient education, not prescribing guidance. It summarizes the published evidence about how this medication has been studied in Black patients — it is not a substitute for the judgment of your personal clinician. Never start, stop, or change a prescription based on something you read here. If you have questions about your medication, call your prescriber or pharmacist. For emergencies, call 911.

Read our editorial standards for how we source, review, and update these pages.